Form 8-K - Current report:
SEC Accession No. 0001157523-20-000944
Filing Date
2020-06-29
Accepted
2020-06-29 16:16:03
Documents
12
Period of Report
2020-06-24
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 USANA HEALTH SCIENCES, INC. 8-K a52242875.htm   iXBRL 8-K 23399
  Complete submission text file 0001157523-20-000944.txt   161216

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA usna-20200624.xsd EX-101.SCH 4186
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE usna-20200624_lab.xml EX-101.LAB 23692
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usna-20200624_pre.xml EX-101.PRE 16824
5 EXTRACTED XBRL INSTANCE DOCUMENT a52242875_htm.xml XML 4086
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 20997599
SIC: 2833 Medicinal Chemicals & Botanical Products